© 2000 BMJ Publishing Group
Letter to the editor
Cheilitis in association with indinavir
Departments of HIV medicine and Dermatology, Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH
Correspondence to:
Dr Fox
Accepted June 19, 2000
EDITOR,There is increasing speculation that indinavir may cause side effects which have been previously associated with high concentrations of retinoids. In the presence of all-trans-retinoic acid (ATRA), indinavir, but not other protease inhibitors (PIs), alters stem cell differentiation in vitro, not seen in the presence of ATRA alone.1 Alopecia and cheilitis are two side effects associated with both retinoids and the protease inhibitor indinavir (but not with any of the other protease inhibitors). These side effects can be reversed on changing from indinavir to an alternative PI.2 We report a case of cheilitis associated with indinavir which resolved rapidly on changing treatment.
A 35 year old African man developed cheilitis (fig 1A) 5 months after commencing HAART with stavudine, lamivudine, and indinavir. His CD4 lymphocyte count at that time was 238 cells x106/l, with an HIV viral load of 78 copies per ml (Chiron bDNA assay
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
